DBS Group Research

Analysts mixed on Frencken after dip in FY2022 earnings and soft FY2023 outlook - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on Frencken after dip in FY2022 earnings and soft FY2023 outlook

The company announced FY2022 ended Dec 31, 2022 earnings of $51.9 million, 11.7% lower than $58.7 million in FY2021.

Broker's Calls

DBS maintains 'buy' call for Daiwa House Logistics Trust, raises TP to 80 cents

The brokerage noted that the “worst is over” for the trust as the yen bottoms out.

Broker's Calls

Sarine losing shine as demand softens, DBS downgrades to 'fully valued' with lower TP of 33 cents

The softness in diamond end markets could trickle down to the midstream, which could dampen Sarine’s revenue.
Analysts keep 'buy' calls on Cromwell after 'good set' of results for FY2022 - THE EDGE SINGAPORE

Broker's Calls

Analysts keep 'buy' calls on Cromwell after 'good set' of results for FY2022

The analysts from DBS and RHB have kept their target prices unchanged at EUR2.10 and EUR2.15 respectively.
Analysts lift Raffles Medical Group's TPs following its 'exceptional year' - THE EDGE SINGAPORE

Broker's Calls

Analysts lift Raffles Medical Group's TPs following its 'exceptional year'

The analysts are now more positive on the prospects of RMG’s Chinese hospitals.

Broker's Calls

ARA US Hospitality Trust 'best poised' among S-REITs to ride US travel demand uptrend: DBS

DBS Group Research has kept its "buy" call on the trust with an unchanged target price of 55 US cents.
ST Engineering set for continued growth in and beyond FY2023 as air travel begins full recovery: analysts - THE EDGE SINGAPORE

Broker's Calls

ST Engineering set for continued growth in and beyond FY2023 as air travel begins full recovery: analysts

Analysts from DBS, CGS-CIMB, OCBC, Maybank and RHB have maintained their "add" or "buy" calls for ST Engineering.
DBS downgrades AEM to 'sell' as it sees 'testing times' ahead - THE EDGE SINGAPORE

Broker's Calls

DBS downgrades AEM to 'sell' as it sees 'testing times' ahead

The team at DBS has also lowered its target price to $2 from $3.19 previously.
×